
01/08/2022
FDA approves ivosidenib in combination with azacitidine for newly diagnosed acute myeloid leukemia
In everything Indian Pharma Network is guided by its core values and code of conduct; Indian Pharma
Delhi
110016
Be the first to know and let us send you an email when Indian Pharma Network, New Delhi posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
Send a message to Indian Pharma Network, New Delhi: